☰

Christina H. Swan, Ph.D. - Publications

Affiliations: 
2006 University of California, San Diego, La Jolla, CA 
Area:
Pathology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Meyerson NR, Rowley PA, Swan CH, Le DT, Wilkerson GK, Sawyer SL. Positive selection of primate genes that promote HIV-1 replication. Virology. 454: 291-8. PMID 24725956 DOI: 10.1016/J.Virol.2014.02.029  0.605
2006 Swan CH, Torbett BE. Can gene delivery close the door to HIV-1 entry after escape? Journal of Medical Primatology. 35: 236-47. PMID 16872287 DOI: 10.1111/J.1600-0684.2006.00172.X  0.71
2006 Swan CH, Bühler B, Steinberger P, Tschan MP, Barbas CF, Torbett BE. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery. Gene Therapy. 13: 1480-92. PMID 16738691 DOI: 10.1038/Sj.Gt.3302801  0.715
2006 Swan CH, Chatterji U, Gallay P, Picker LJ, Torbett BE. 760. Overcoming Rhesus Macaque Endogenous Restriction Factors during HIV-1 Vector Transduction Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.844  0.762
2005 Swan CH, Chatterji U, Gallay P, Torbett BE. A Cyclophilin A-Independent Capsid Motif Renders HIV-1 Derived Vectors More Efficient at Transducing Human Cells. Blood. 106: 5531-5531. DOI: 10.1182/Blood.V106.11.5531.5531  0.738
2005 Swan CH, Tschan MP, Barbas CF, Torbett BE. 1001. Knockdown of CXCR4 Expression Sufficient for Blocking HIV-1-Infection Requires Combinatorial Intrabody and siRNA Mediated HIV-1 Vector Gene Delivery Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.548  0.76
2005 Swan CH, Fischer KM, Bühler B, Tschan MP, Barbas CF, Torbett BE. 973. Targeting of CCR5 through Intrabody Mediated HIV-1 Vector Gene Delivery Is Sufficient for Blocking HIV-1-Infection and Confers a T-Cell Survival and Growth Advantage Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.516  0.749
2004 de Rozières S, Swan CH, Sheeter DA, Clingerman KJ, Lin YC, Huitron-Resendiz S, Henriksen S, Torbett BE, Elder JH. Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3. Retrovirology. 1: 38. PMID 15555065 DOI: 10.1186/1742-4690-1-38  0.578
2004 Segal DJ, Gonçalves J, Eberhardy S, Swan CH, Torbett BE, Li X, Barbas CF. Attenuation of HIV-1 Replication in Primary Human Cells with a Designed Zinc Finger Transcription Factor Journal of Biological Chemistry. 279: 14509-14519. PMID 14734553 DOI: 10.1074/Jbc.M400349200  0.724
2004 Swan CH, Tschan MP, Barbas CF, Torbett BE. Development of a Unique siRNA and Intrabody Combinatorial HIV-1 Vector to Knockdown CXCR4 and Protect Cells from HIV-1 Challenge. Blood. 104: 1757-1757. DOI: 10.1182/Blood.V104.11.1757.1757  0.75
2004 Swan CH, Buhler B, Tschan MP, Barbas CF, Torbett BE. Lentiviral CCR5 Intrabody Gene Delivery Provides Protection and Enrichment during CCR5-Tropic Infection. Blood. 104: 1755-1755. DOI: 10.1182/Blood.V104.11.1755.1755  0.766
Show low-probability matches.